An increase in the populations of CD34+ and HLA-DRAhi fibroblasts, particularly noted in RA patients, correlated with more severe and persistent inflammation, alongside a reduction in DKK3+ and CD55+ fibroblasts. This evidence concerns the gene CD34 and rheumatoid arthritis.